Single Arm, Phase I Clinical Study of HS-IT101 Injection in the Treatment of Advanced Solid Tumors
Latest Information Update: 05 Apr 2024
At a glance
- Drugs HS-IT-101 (Primary)
- Indications Solid tumours
- Focus Adverse reactions
- Sponsors Qingdao Sino-Cell Biomedicine
Most Recent Events
- 05 Apr 2024 New trial record